What can we learn from treatment-induced changes in rheumatoid factor and anti-citrullinated Peptide antibodies?
Bobbio-Pallavicini, F.; Caporali, R.; Bugatti, S.; Montecucco, C.
Journal of Rheumatology 35(10): 1903-1905
2008
ISSN/ISBN: 0315-162X PMID: 18843754 Document Number: 616175
Document emailed within 1 workday
Related Documents
Sihvonen, S.; Korpela, M.; Mustila, A.; Mustonen, J. 2005: The predictive value of rheumatoid factor isotypes, anti-cyclic citrullinated peptide antibodies, and antineutrophil cytoplasmic antibodies for mortality in patients with rheumatoid arthritis Journal of Rheumatology 32(11): 2089-2094Kuru, O.; Bilgici, A.; Birinci, A.; Ulusoy, H.; Durupinar, B. 2009: Prognostic value of anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis Bratislavske Lekarske Listy 110(10): 650-654
Barcelos, F.; Abreu, I.; Patto, J.é V.; Trindade, H.él.; Teixeira, A. 2009: Anti-cyclic citrullinated peptide antibodies and rheumatoid factor in Sjögren's syndrome Acta Reumatologica Portuguesa 34(4): 608-612
Yalaoui, S. 2006: Anti-citrullinated peptide antibodies: novel markers for rheumatoid polyarthritis Archives de l'Institut Pasteur de Tunis 83(1-4): 13-17
Hayashi, N.; Kumagai, S. 2010: Anti-cyclic citrullinated peptide antibodies and rheumatoid arthritis Rinsho Byori. Japanese Journal of Clinical Pathology 58(5): 466-479
Sun, J.; Zhang, Y.; Liu, L.; Liu, G. 2014: Diagnostic accuracy of combined tests of anti cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis: a meta-analysis Clinical and Experimental Rheumatology 32(1): 11-21
Yamane, T.; Hashiramoto, A.; Tanaka, Y.; Tsumiyama, K.; Miura, Y.; Shiozawa, K.; Chihara, K.; Shiozawa, S. 2008: Easy and accurate diagnosis of rheumatoid arthritis using anti-cyclic citrullinated peptide 2 antibody, swollen joint count, and C-reactive protein/rheumatoid factor Journal of Rheumatology 35(3): 414-420
Awwad, H.M.; Aboukhamis, I.A. 2010: Diagnostic Performances of Anti-Cyclic Citrullinated Peptide Antibodies type IgM, IgA and IgG in Syrian Patients with Rheumatoid Arthritis Clinical Laboratory 56(3-4): 95-102
Lequerré, T.; Richez, C. 2012: Anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: the best diagnostic tool but also a great interest in prognosis La Revue du Praticien 62(8): 1088-1089
Kim, D.-A.; Jearn, L.-H.; Kim, T.-Y. 2007: Antiperinuclear factor test is more useful than anti-Sa assay when used with anti-cyclic citrullinated peptide test in diagnosis of rheumatoid arthritis Journal of Rheumatology 34(9): 1944-1945
Girelli, F.; Foschi, F.G.; Bedeschi, E.; Calderoni, V.; Stefanini, G.F.; Martinelli, M.G. 2004: Is Anti Cyclic citrullinated peptide a useful laboratory test for the diagnosis of rheumatoid arthritis? European Annals of Allergy and Clinical Immunology 36(4): 127-130
Toes, R.E.; van der Woude, D. 2011: ACPA (anti-citrullinated protein antibodies) and rheumatoid arthritis Acta Reumatologica Portuguesa 36(3): 205-207
Ramírez, Súl.; Ramírez, Mía.G.; Muñoz, Jé.F.; Martínez, G.E.; Velarde, E.E.; Sánchez, P.E. 2019: Association of KIR2DL2 gene with anti-cyclic citrullinated protein antibodies for serodiagnosis in rheumatoid arthritis Medicina 79(3): 161-166
Jansen, T.L.T.A.; Bruyn, G.A.W. 2004: Diagnostic value of anticyclic citrullinated peptide antibody in rheumatoid arthritis Journal of rheumatology 31(5): 1012-3; author reply 1013
Rezuş, E.; Grigoriu, A.; Rezuş, C. 2009: Aggressive nature of rheumatic arthritis with citrullinated cyclic peptide antibodies Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 113(1): 73-78
Du Toit, R.ët.; Whitelaw, D.; Taljaard, J.J.; du Plessis, L.; Esser, M. 2011: Lack of specificity of anticyclic citrullinated peptide antibodies in advanced human immunodeficiency virus infection Journal of Rheumatology 38(6): 1055-1060
Sawada, T.; Kanzaki, T.; Hashimoto, S.; Suzuki, A.; Yamada, R.; Odawara, M.; Yamamoto, K. 2009: Citrullinated antigens as C1q-binding and monoclonal rheumatoid factor (mRF)-binding peptides in synovial fluids from rheumatoid arthritis patients Clinical and Experimental Rheumatology 27(6): 989-992
Cherkasova, M.V.; Novikov, A.A.; Alexndrova, E.N.; Karateev, D.E.; Popkova, T.V.; Luchikhina, E.L.; Avdeeva, A.S.; Nasonov, E.L. 2015: The clinical informativeness of detection of antibodies to citrullinated proteins under rheumatoid arthritis Klinicheskaia Laboratornaia Diagnostika 60(2): 46-49
Youinou, P.; Le Goff, P.; Miossec, P.; Moineau, M.P.; Ferec, C. 1983: Relation between antiperinuclear factors, anti-keratin antibodies and the agglutinating and non-agglutinating rheumatoid factor in chronic polyarthritis Zeitschrift für Rheumatologie 42(1): 36-39
Piaggio, M.V.; Demonte, A.M.; Sihufe, G.; Garcilazo, S.; Esper, M.C.; Wagener, M.; Aleanzi, M. 1999: Serological diagnosis of celiac disease: anti-gliadin peptide antibodies and tissue anti-transglutaminase Medicina 59(6): 693-697